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ABSTRACT
Autofluorescence of the cornea within specific wavelength region and dynamic light scattering measurements
of ocular tissue have both been used for early-stage detection of the presence of diabetic retinopathy. In the
present study, autofluorescence of the cornea and dynamic light scattering in the cornea and vitreous have
been measured and compared using two innovative research instruments in twenty-two insulin-dependent
diabetes mellitus patients, for the diagnosis of diabetic retinopathy. Corneal autofluorescence mean values in
each diabetic retinopathy grade significantly correlated with dynamic light scattering measurements in the
vitreous, and in the cornea, thus confirming that changes in the natural fluorescence is strictly correlated with
molecular changes of ocular tissues. © 1998 Society of Photo-Optical Instrumentation Engineers. [S1083-3668(98)01103-4]
Keywords dynamic light scattering; corneal autofluorescence; ophthalmic instrument.
1 INTRODUCTION
It is known that diabetic mellitus (DM) is associated
with a number of biochemical alterations in the eye
as well as in other organs. Such alterations are gly-
cosylation of macroproteins and other metabolic
disorders.1–4 In general, the longer the DM dura-
tion, the more marked these alterations. In diabet-
ics, an average prevalence of 52% of diabetic retin-
opathy (DR) has been reported.5 Diabetic
alterations not only affect the retina: in early stages,
alterations of the cornea,6,7 aqueous,8 lens,9,10 and
vitreous11,12 appear. In the vitreous, the three-
dimensional structure of the collagen fibers and the
embedded hyaluronic acid molecules alter their ter-
tiary structure in response to changes of their gly-
cosylation and crosslinking.13 These changes at the
molecular level may occur before any alteration in
the retina can be observed by means of biomicros-
copy. On the other hand, the vascular component of
DM is interrelated to the metabolic disorder that
also affects corneal tissues, resulting in an increase
of the corneal autofluorescence (AF) emitted,
among others, by the Schiff Base crosslinks of gly-
cosylated macroproteins. In previous studies the re-
lation between corneal autofluorescence14,15 and dy-
namic light scattering (DLS) of ocular tissues16–18
have been investigated as a function of the grade of
DR.
In the present study, corneal AF and the distribu-
tion of relaxation rate obtained by DLS measure-
ments in the posterior vitreous and cornea were de-
termined in insulin-dependent diabetes mellitus
(IDDM) patients with three different grades of ret-
inopathy, using systems specifically designed for
possible use in-vivo as screening instruments. The
two methods are compared in order to assess their
usefulness as an indicator of the severity of DR.
2 DESCRIPTION OF THE SYSTEMS
2.1 DYNAMIC LIGHT SCATTERING
ANALYZER
Dynamic light scattering is a well-known technique
for the measurement of the random thermal move-
ments of suspended particles, macromolecule solu-
tions, and other complex liquid systems.19 The in-
formation achievable by DLS measurements is
contained in the shape of the intensity autocorrela-
tion function of the scattered light.
When the motion of the scattering centers is
mainly Brownian, the autocorrelation function de-
creases monotonically to a final value ideally equal
to one half of the initial value. A common way to
extract information from the autocorrelation func-
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tion is via the analysis of its distribution of the re-
laxation rate. The distribution of the relaxation rate
can be used to determine the protein size distribu-
tion in the volume under test (VUT) when the ex-
periment is performed in vitro. Unfortunately,
when the VUT is located in living eyes, the reduced
freedom imposed by membranes and interactions
between scattering centers may affect this interpre-
tation. Therefore, the distribution of relaxation rate
has been selected as a fingerprint of the ocular tis-
sue under test. This approach, even if qualitative,
has been proven to be efficient for diagnostic
purposes.18
The human eye has the unique advantage of be-
ing transparent (to visible and near infrared radia-
tion). Thus, several eye compartments with differ-
ent kinds of macroproteins are accessible to
examination by DLS.20
Structural alterations of the vitreous, associated
with DM, can be detected by DLS.18 However, mea-
surements are critical due to the limited scattering
of these ocular tissue (the vitreous scatters roughly
thirty times less than the lens), eye movements
which are greatest at the anterior and posterior
pole, and eye blinking. Moreover, the limited acces-
sibility through the pupil as well as laser power
safety considerations require the use of very high
sensitivity DLS apparatus. Recently, with the help
of high sensitivity instruments, first investigations
of pathological process in the vitreous have been
reported.21,22
In this experimental activity, DLS measurements
on corneal and vitreal tissues have been performed
with excitation laser beam power as small as 5–30
mW. An outline of the measuring system is shown
in Figure 1(a). The instrument consists of three
main blocks: (i) the microscope extension, (ii) the
control unit, and (iii) the digital correlator con-
nected to a PC. The control unit and the microscope
extension are connected by a pair of 3-m-long,
single-mode optical fibers. The microscope exten-
sion is built into a standard ophthalmic microscope
(mod. 900 BQ, Haag-Streit AG, Switzerland). Hol-
low excitation beam and single-mode fiber detector
have been used to improve system performance, al-
lowing reliable DLS measurements in the vitreous.
The hollow beam geometry allows optimal utili-
zation of the pupil aperture for focusing of the ex-
citation beam.23 The medical operator can observe
the VUT directly and exploit the reflected annular
beam at different interfaces to determine with suf-
ficient precision the VUT position along the eye
axis. For example, when the VUT is located in the
middle of the cornea, the operator can see, by the
binocular of the slit lamp, two identical rings back-
reflected by the corneal epithelium and endothe-
lium; whereas, when the VUT is located in the vit-
reous, the ring diameter projected on the retina is
inversely proportional to the distance from the reti-
nal tissue.
A digital correlator (ALV-5000, ALV Lagen, Ger-
many) is used for signal processing. This correlator
employs the so called ‘‘symmetrical normalization
scheme’’ and is, therefore, suitable for short
averaging-time measurements. This fact can be ex-
ploited to reject artifacts due to eye blinking and
movement averaging the data from five short mea-
surement cycles during a period of 10 s.
2.2 CORNEAL FLUOROMETER
Recently, corneal autofluorescence has been pro-
posed as an ocular diagnostic tool for DR.14,15 The
method is based on the sensible increase of the
natural fluorescence of the corneal tissue within
specific wavelength in the presence of the early
stage of DR. The main advantages of this method
are that corneal autofluorescence has been demon-
strated to be unrelated to age and that the cornea is
readily accessible for investigation.
The epithelium and the endothelium contains py-
ridine nucleotide and flavoproteins. The pyridine
nucleotide shows fluorescence in the reduced state
whereas flavoproteins show fluorescence in the oxi-
dated form. The accumulation of these fluoro-
phores in diabetic cornea related to the duration of
diabetes cannot adequately explain the increased
autofluorescence in patients with retinopathy.13
Two speculative explanations have so far been re-
Fig. 1 (a) Outline of the instrument for dynamic light scattering
measurements. The instrument consists of three main blocks: (i) the
microscope extension, (ii) the control unit, and (iii) the digital cor-
relator connected to a PC. (b) Principle scheme of the instrument for
corneal autofluorescence measurements. The excitation light from
two blue LEDs passes through the excitation filters (460–480 nm).
A suitable set of emission filters (500–540 nm) selects the wave-
lengths of interest, which are detected by the photomultiplier tube
(PMT). The current signal at the output of the PMT is processed
using custom front-end electronics.
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ported: (i) the vascular component of DM causing
specific microangiopathy and consequently pro-
gressive retinopathy may induce a general meta-
bolic disorder resulting in an increase of the corneal
autofluorescence, or (ii) neovascularization mediat-
ing substances produced in the retina with retin-
opathy and inducing neovascularization of the iris
may reach the cornea as well and consequently in-
duce changes in the corneal metabolism resulting in
increased value of AF.14
In the present study, corneal AF has been mea-
sured by a dedicated research instrument24 using
side illumination of the cornea by blue light emit-
ting diodes (LED) light sources. Figure 1(b) shows
the principle scheme of this instrument. The excita-
tion light from two blue LEDs passes through a
suitable set of barrier filters and impinges tangen-
tially on the patients’ cornea. The excitation light so
obtained has a spectrum included between 460 and
480 nm. The fluorescence light from the cornea is
collected axially using a camera objective. A suit-
able set of emission filters select the wavelengths of
interest (500–540 nm). The fluorescence light is then
converted to an electric signal by a photomultiplier
tube (PMT). The current signal at the output of the
photomultiplier tube is processed using custom
front-end electronics. The AF data are recorded in
sixteen measurement cycles during a period of 10 s
and the average value is considered.
3 EXPERIMENTAL
3.1 SUBJECT SELECTION
Twenty-two IDDM patients aged 16–73 years par-
ticipated in this study, and were selected from the
Eye Clinic of the University of Zu¨rich. Great care
was taken to select patients with normal aspect of
all cornea layers and of the vitreous assessed by slit
lamp examination. Individuals with contact lenses
were excluded.
The modified Airlie House classification was
used to grade the DR according to the following
three grades:
Grade 1. No or negligible retinopathy; at most
two microaneurysms per field.
Grade 2. Background or nonproliferative retin-
opathy; three or more microaneurysms per field, or
one or more of the following items: retinal hemor-
rhages, hard or soft exudated and/or interetinal
microvascular abnormalities (IRMA), venous bead-
ing.
Grade 3. (Pre-) proliferative retinopathy; hemor-
rhages and microaneurysms, and the following fea-
tures present in more than two fields: soft exudates,
IRMA, venous beading, and/or new vessel and fi-
brous proliferations, and/or vitreous hemorrhages.
Mean and standard deviation of the patients’ age
in the three groups are presented in Table 1.
3.2 DATA ANALYSES
Two DLS measurements in the posterior part of the
vitreous and one in the cornea were performed in
each eye using the instrument presented in Figure
1(a). The second measurement in the vitreous was
used to establish that the first measurement had not
been performed in spatial nonuniformity. Typical
autocorrelation functions for in vitro measurement
of a dilute sample of polystyrene latex spheres
(nominal radius 91 nm) and for in vivo measure-
ments of corneal and in the vitreal tissue are shown
in Figure 2. The amplitude of the dynamic part of
the normalized autocorrelation function, known
also as S/N ratio of the autocorrelation function,
approaches the theoretical limiting value of 1 for
the in vitro measurement, whereas, for in vivo mea-
surements in the cornea and in the vitreous, it is in
the order of 0.8 and 0.4, respectively. The reduction
of this parameter for in vivo measurements with re-
spect to the theoretical limit is mainly due to stray
light from interfaces and static scattering centers.
Nevertheless, these S/N ratios are adequate for a
correct data analysis.
Fig. 2 Typical autocorrelation functions for dilute sample of poly-
styrene latex spheres (nominal radius 91 nm) and for in vivo mea-
surements in the cornea and in the vitreous. The amplitude of the
dynamic part of the normalized autocorrelation function ap-
proaches the theoretical limiting value of 1 for the in vitro measure-
ment, whereas, for in vivo measurements in the cornea and in the
vitreous, it is in the order of 0.8 and 0.4, respectively.
Table 1 Mean and standard deviation of the patients’ age in the
three groups: grade 1: No or negligible retinopathy; grade 2:
Background or nonproliferative retinopathy; grade 3: (Pre-) prolif-
erative retinopathy.
Group
Number of
individuals
Age (year)
(Mean6SD)
Grade 1 4 52616.70
Grade 2 4 7364.35
Grade 3 14 56616.20
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The determined autocorrelation functions were
analyzed using the program CONTIN (ALV Langen,
Germany). This program performs the inverse
Laplace transform of the autocorrelation function to
obtain the distribution of relaxation rate. As shown
in Figure 3, the typical spectrum exhibits a se-
quence of peaks with different amplitudes.
Two parameters were used to characterized the
ocular tissues under test: (i) the abscissa Gam-
ma[max, measuring position] of the peak at the
maximum amplitude and (ii) the center of gravity
of the relaxation rate distribution, defined as:
Gamma[g, measuring position]5
( i51
n G iAi
( i51
n Ai
,
(1)
where G i and Ai are the abscissa and the amplitude
of each peak, respectively (Figure 3). Average of the
two measurements in the vitreous was calculated.
Three corneal autofluorescence measurements
were performed in each eye, a few minutes after
DLS examinations, using the ocular fluorometer.
These measurements were performed in different
corneal regions and the average value of the results
were calculated. This operation minimizes the ef-
fect of spatial nonuniformity.
The two examinations were performed within a
time interval of about 5 min. Artifacts due to eye
blinking and movement were minimized by aver-
aging data from five measurement cycles of 2 s for
DLS measurements and performing three AF mea-
surements in each eye.
3.3 RESULTS
Mean and standard deviation of the DLS data and
the corneal AF in each retinopathy grade are re-
ported in Table 2. Experimental data was analyzed
using the Mann–Whiter nonparametric test (Statis-
tica, Statsoft Inc.). An average increase of about 70%
(p50.06) of the corneal AF between patients with
negligible DR (grade 1) and with background DR
(grade 2) was observed. Corneal AF mean value of
patients with (pre-) proliferative DR (grade 3) de-
creases by about 26% (p50.13) with respect to
background DR (grade 2).
The Gamma[max, vitreous] mean value of pa-
tients with background DR (grade 2) were higher
(about 45%, p50.19) when compared to mean val-
ues obtained with patients with both negligible
(grade 1) or (pre-) proliferative DR (grade 3). Neg-
ligible dependence of the Gamma[max, cornea] val-
ues from the DR grade was observed (p50.8).
The Gamma[g, cornea] exhibited a significant de-
pendence to the grade of DR. In patients with a
negligible DR (grade 1), the Gamma[g, cornea]
mean value was significantly higher (about 8.7
times, p50.0005) than in patients with background
DR (grade 2). Patients with (pre-) proliferative DR
(grade 3) exhibit an intermediate value of Gam-
ma[g, cornea]. Negligible dependence of the Gam-
ma[g, vitreous] from the DR was observed
(p50.8).
The most significant parameters, i.e., mean values
and standard errors of corneal AF, Gamma[max,
vitreous], and Gamma[g, cornea], as a function of
the DR grade are shown in Figures 4(a)–4(c).
In Figures 5(a)–5(c) the mean values of corneal
AF, Gamma[max, vitreous], and Gamma[g, cornea]
as a function of the patients’ age are shown. Cor-
neal AF means values in each DR grade correlated
with Gamma[max, vitreous] and Gamma[g, cornea]
as shown in Figures 6(a) and 6(b), respectively.
Fig. 3 Typical distribution of relaxation rate obtained performing
the inverse Laplace transform of the autocorrelation function. The
measurement has been performed in the cornea of a patient with
retinopathy grade 1.
Table 2 Effect of diabetic retinopathy on corneal autofluorescence (AF) and dynamic light scattering results (Gamma[max, measuring
position], Gamma[g, measuring position]). Gamma[max, measuring position] is the abscissa of the peak at the maximum amplitude of the
relaxation rate distribution and Gamma[g, measuring position] is the center of gravity of the relaxation rate distribution.
Group
Corneal AF (A.U.)
(Mean6SD)
Gamma[max,vitreous]
(1/ms) (Mean6SD)
Gamma[max,cornea]
(1/ms) (Mean6SD)
Gamma[g,cornea]
(1/ms) (Mean6SD)
Gamma[g,vitreous]
(1/ms) (Mean6SD)
Grade 1 0.9560.650 0.40660.330 0.38160.258 2.9362.380 3.6962.740
Grade 2 1.6160.740 0.59960.280 0.38360.385 0.3060.148 4.0662.430
Grade 3 1.1960.640 0.46260.220 0.38060.213 1.1061.220 4.7963.530
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3.4 DISCUSSION
The present study demonstrates that both DLS in
ocular tissue and corneal AF could be efficiently
used for an early diagnosis of DR. High sensitivity
and specificity could be obtained from corneal AF
and Gamma[g, cornea] by fixing a proper threshold
to discriminate negligible (grade 1) to background
DR (grade 2). These two parameters are not suitable
to classify DR grade, since (pre-) proliferative DR
(grade 3) could easily be confused with negligible
DR (grade 1). Metabolic changes due to DR were
observed using both DLS in the corneal tissue and
corneal AF. The increase of the corneal AF between
patients with negligible DR (grade 1) and with
background DR (grade 2) was associated with a
marked decrease in the mean value of Gamma[g,
cornea]. This could be due to a metabolic disorder
that results in an increase of the mean radius of the
scattering molecules. However, it could be also re-
lated to a decrease of the molecular mobility, due
for example to an increase of the local viscosity, or
to interactions between scattering centres. Note that
the decrease in the corneal AF between patients
with background DR (grade 2) and with (pre-) pro-
liferative DR (grade 3) is associated with an in-
crease of Gamma[g, cornea] in the cornea. The high
correlation between corneal AF means values and
Gamma[g, cornea] [Figure 6(a)] demonstrates that
changes in AF are induced by a structural change in
the corneal tissue. No significant correlation with
patients’ age was observed for corneal AF, Gam-
ma[max, vitreous], and Gamma[g, cornea].
Glycosylation of the hyaluronate molecules as
well as the presence of pathologic plasma proteins,
as may occur with a partial breakdown of the
blood-retinal barrier (BRB) during the course of
DM, alters the tertiary and quaternary structure of
the vitreous molecules as well as their diffusivity.
Such changes are known from other tissues.25 In the
vitreous they can be detected by DLS at a time
when there are no visible alterations and no onset
of DR. Because the breakdown of BRB causes sig-
nificant changes of protein concentration in the vit-
reous first and then alterations of the corneal tissue,
DLS in the vitreous should be more effective for an
early detection of DR. It may be assumed that alter-
ations due to DR manifest in the vitreous before the
cornea due to the close spatial location of the vitre-
ous and the retina. The increase of the Gam-
ma[max, vitreous] between patients with negligible
Fig. 4 (a) Corneal autofluorescence expressed in arbitrary units, (b) Gamma[max, vitreous] values expressed in 1/ms, and (c) Gamma[g,
cornea] values expressed in 1/ms. Retinopathy is graded using the modified Airlie House classification (see the text). The closed squares and
bars represent the mean value and the standard error of the mean in each group.
Fig. 5 (a) Corneal autofluorescence, (b) Gamma[max, vitreous] values, and (c) Gamma[g, cornea] values as a function of the patients’ age.
Open squares: patients with retinopathy grade 1, i.e., no or negligible retinopathy. Closed squares: patients with retinopathy grade 2, i.e.,
background or nonproliferative retinopathy. Crosses: patients with retinopathy grade 3, i.e., (pre-) proliferative retinopathy.
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DR (grade 1) and with background DR (grade 2)
could be due to alteration of the tertiary and qua-
ternary structure of the vitreous molecules as well
as their diffusivity. Even the mean value of Gam-
ma[max, vitreous] significantly correlates with cor-
neal AF [Figure 6(b)], confirming that the two phe-
nomena are strictly connected. Nevertheless,
corneal AF can be measured easily without burden
to the patient. Theoretical advantages of vitreal
measurements need to be investigated further un-
der practical and clinical aspects.
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